How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group

被引：28

作者：

Ferretti, Francesca ^{[1
]}

Cannatelli, Rosanna ^{[1
]}

Benucci, Maurizio ^{[2
]}

Carmagnola, Stefania ^{[1
]}

Clementi, Emilio ^{[3
,4
]}

Danelli, Piergiorgio ^{[5
]}

Dilillo, Dario ^{[6
]}

Fiorina, Paolo ^{[7
,8
,9
]}

Galli, Massimo ^{[10
]}

Gallieni, Maurizio ^{[11
,12
]}

Genovese, Giovanni ^{[1
,13
,14
]}

Giorgi, Valeria ^{[15
]}

Invernizzi, Alessandro ^{[16
,17
]}

Maconi, Giovanni ^{[1
]}

Maier, Jeanette A. ^{[11
]}

Marzano, Angelo V. ^{[14
]}

Morpurgo, Paola S. ^{[7
]}

Nebuloni, Manuela ^{[18
]}

Radovanovic, Dejan ^{[19
]}

Riva, Agostino ^{[11
]}

Rizzardini, Giuliano ^{[20
,21
]}

Sabiu, Gianmarco ^{[11
]}

Santus, Pierachille ^{[11
,19
]}

Staurenghi, Giovanni ^{[16
]}

Zuccotti, Gianvincenzo ^{[6
]}

Sarzi-Puttini, Pier Carlo ^{[15
]}

Ardizzone, Sandro ^{[1
]}

机构：

[1] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Gastroenterol Unit, ASST Fatebenefratelli Sacco, Milan, Italy

[2] S Giovanni Dio Hosp, Rheumatol Unit, Azienda USL Toscana Ctr, Florence, Italy

[3] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Unit Clin Pharmacol, Milan, Italy

[4] Sci Inst IRCCS E Medea, Lecce, Italy

[5] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Surg Unit, ASST Fatebenefratelli Sacco, Milan, Italy

[6] Univ Milan, Pediat Dept, Dept Biomed & Clin Sci DIBIC L Sacco, Osped Bambini,ASST Fatebenefratelli Sacco, Milan, Italy

[7] ASST Fatebenefratelli Sacco, Div Endocrinol, Milan, Italy

[8] Univ Milan, Int Ctr T1D, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, DIBIC, Milan, Italy

[9] Harvard Med Sch, Boston Childrens Hosp, Nephrol Div, Boston, MA 02115 USA

[10] Univ Milan, Univ Hosp Luigi Sacco, Dept Biomed & Clin Sci DIBIC L Sacco, Infect Dis Unit 3, Milan, Italy

[11] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Milan, Italy

[12] L Sacco Hosp Vialba, Nephrol & Dialysis Unit, ASST Fatebenefratelli Sacco, Milan, Italy

[13] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[14] Univ Milan, Dermatol Unit, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[15] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Rheumatol Unit, Milan, Italy

[16] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Eye Clin, Milan, Italy

[17] Univ Sydney, Save Sight Inst, Sydney Med Sch, Discipline Ophthalmol, Sydney, NSW, Australia

[18] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Pathol Unit, Milan, Italy

[19] Osped L Sacco, Div Resp Dis, ASST Fatebenefratelli Sacco, Milan, Italy

[20] Univ Milan, Dept Infect Dis, ASST Fatebenefratelli Sacco, Milan, Italy

[21] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa

来源：

FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷

关键词：

COVID-19; Sars-CoV-2; vaccine; IMIDs; chronic disease; prevention; EFFICACY; RISK;

D O I：

10.3389/fimmu.2021.656362

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and daily routine around the world. Huge efforts from pharmacological industries have led to the development of COVID-19 vaccines. In particular two mRNA vaccines, namely the BNT162b2 (Pfizer-BioNTech) and the mRNA-1273 (Moderna), and a viral-vectored vaccine, i.e. ChAdOx1 nCoV-19 (AstraZeneca), have recently been approved in Europe. Clinical trials on these vaccines have been published on the general population showing a high efficacy with minor adverse events. However, specific data about the efficacy and safety of these vaccines in patients with immune-mediated inflammatory diseases (IMIDs) are still lacking. Moreover, the limited availability of these vaccines requires prioritizing some vulnerable categories of patients compared to others. In this position paper, we propose the point of view about the management of COVID-19 vaccination from Italian experts on IMIDs and the identification of high-risk groups according to the different diseases and their chronic therapy.

引用

页数：14

共 50 条

[31] Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak
Veenstra, Jesse
Buechler, Connor R.
Robinson, Gabrielle
Chapman, Stephanie
Adelman, Madeline
Tisack, Aaron
Dimitrion, Peter
Todter, Erika
Kohen, Laurie
Lim, Henry W.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : 1696 - 1703
[32] Exacerbation of Immune-mediated Inflammatory Diseases in COVID19 Sequelae
Caetano, Camila
Azamor, Tamiris
Meyer, Nikki M.
Calabrese, Cassandra
Calabrese, Leonard
Piuzzi, Nicolas
Husni, M. Elaine
Foo, Suan-Sin
Chen, Weiqiang
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3317 - 3318
[33] COVID-19 Impact and Vaccination Willingness among Romanian Patients with Autoimmune/Immune-Mediated Diseases
Pinte, Larisa
Caraiola, Simona
Balaban, Daniel Vasile
Badea, Camelia
Mazilu, Diana
Ionescu, Georgeta Daniela
Iosub, Maria-Ilinca
Balan, Elena-Sabina
Negoi, Florentina
Dumitrescu, Bianca
Mateescu, Bogdan
Ionescu, Ruxandra
Parvu, Magda Ileana
Baicus, Cristian
HEALTHCARE, 2021, 9 (12)
[34] The safety of COVID-19 vaccination in immunocompromised children and young adults with immune-mediated inflammatory disease
Sahn, Benjamin
Lu, Ying
Hui-Yuen, Joyce S. S.
Fishbein, Joanna
Gottlieb, Beth S. S.
Eberhard, Barbara A. A.
Walters, Heather M. M.
ACTA PAEDIATRICA, 2023, 112 (04) : 794 - 801
[35] Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care
Umer Syed
Anuradhaa Subramanian
David C. Wraith
Janet M. Lord
Kirsty McGee
Krishna Ghokale
Krishnarajah Nirantharakumar
Shamil Haroon
BMC Medicine, 21
[36] Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care
Syed, Umer
Subramanian, Anuradhaa
Wraith, David C.
Lord, Janet M.
McGee, Kirsty
Ghokale, Krishna
Nirantharakumar, Krishnarajah
Haroon, Shamil
BMC MEDICINE, 2023, 21 (01)
[37] Severity Factors of Covid-19 Infection in Rheumatic Immune-mediated Inflammatory Diseases: Study in a Single University Hospital
Martinez-Lopez, David
Prieto-Pena, Diana
Sanchez-Bilbao, Lara
Alvarez-Reguera, Carmen
Herrero-Morant, Alba
Benavides-Villanueva, Fabricio
Corrales-Selaya, Cristina
Trigueros-Vazquez, Martin
Angel Gonzalez-Gay, Miguel
Blanco, Ricardo
Wallmann, Reinhard
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3210 - 3212
[38] COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATED INFLAMMATORY DISEASES. EPIDEMIOLOGICAL STUDY IN A SINGLE UNIVERSITY HOSPITAL
Martinez-Lopez, D.
Prieto-Pena, D.
Sanchez-Bilbao, L.
Herrero-Morant, A.
Alvarez-Reguera, C.
Trigueros-Vazquez, M.
Gonzalez-Gay, M. A.
Blanco, R.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 899 - 899
[39] Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
Picod, Adrien
Rebibou, Jean-Michel
Dossier, Antoine
Cador, Berengere
Ribes, David
Vasco-Moynet, Claire
Stephan, Caroline
Bellal, Mathieu
Wynckel, Alain
Poullin, Pascale
Peju, Edwige
Ricard, Laure
Kahn, Jean-Emmanuel
Bouzid, Raida
Benhamou, Ygal
Joly, Berangere
Veyradier, Agnes
Coppo, Paul
BLOOD, 2022, 139 (16) : 2565 - +
[40] IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES TAKING A BIOLOGIC THERAPY
Halioua, B.
Zetlaoui, J.
Astruc, A.
Testa, D.
Bombezin-Domino, A.
Radoszycki, L.
VALUE IN HEALTH, 2020, 23 : S622 - S622

← 1 2 3 4 5 →